Eaton Vance Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $560K | Hold |
10,009
| – | – | ﹤0.01% | 1327 |
|
|
2022
Q2 | $518K | Sell |
10,009
-1,000
| -9% | -$51.8K | ﹤0.01% | 1366 |
|
|
2022
Q1 | $800K | Hold |
11,009
| – | – | ﹤0.01% | 1417 |
|
|
2021
Q4 | $1.3M | Hold |
11,009
| – | – | ﹤0.01% | 1125 |
|
|
2021
Q3 | $1.34M | Hold |
11,009
| – | – | ﹤0.01% | 1014 |
|
|
2021
Q2 | $1.78M | Buy |
11,009
+308
| +3% | +$49.9K | ﹤0.01% | 1039 |
|
|
2021
Q1 | $859K | Buy |
+10,701
| New | +$859K | ﹤0.01% | 1162 |
|